AMNEAL PHARMACEUTICALS, INC. Goodwill, Acquired During Period
AMNEAL PHARMACEUTICALS, INC. (AMRX) reported Goodwill, Acquired During Period of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-14.
Discontinued › Notes › Goodwill and Other
us-gaap:GoodwillAcquiredDuringPeriod · last filed 2024-03-14
- AMNEAL PHARMACEUTICALS, INC. goodwill, acquired during period for the quarter ending 2023-12-31 was $0.00.
- AMNEAL PHARMACEUTICALS, INC. goodwill, acquired during period for the quarter ending 2023-09-30 was $0.00.
- AMNEAL PHARMACEUTICALS, INC. goodwill, acquired during period for the quarter ending 2023-06-30 was $0.00.
- AMNEAL PHARMACEUTICALS, INC. goodwill, acquired during period for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- AMNEAL PHARMACEUTICALS, INC. goodwill, acquired during period for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- AMNEAL PHARMACEUTICALS, INC. goodwill, acquired during period for fiscal 2022 was $7.55M, a 89.30% decline from fiscal 2021.
- AMNEAL PHARMACEUTICALS, INC. goodwill, acquired during period for fiscal 2021 was $70.58M, a 31.92% decline from fiscal 2020.
- AMNEAL PHARMACEUTICALS, INC. goodwill, acquired during period for fiscal 2020 was $103.68M.
| Period end | Goodwill, Acquired During Period 3 month | Goodwill, Acquired During Period 6 month | Goodwill, Acquired During Period 9 month | Goodwill, Acquired During Period 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $0.00 derived: sum of 2 quarters · filed 2024-03-14 | $0.00 derived: sum of 3 quarters · filed 2024-03-14 | $0.00 10-K · filed 2024-03-14 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | $0.00 derived: sum of 4 quarters · filed 2024-03-14 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | $0.00 derived: sum of 3 quarters · filed 2024-03-14 | $0.00 derived: sum of 4 quarters · filed 2024-03-14 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-09 | $0.00 derived: sum of 2 quarters · filed 2024-03-14 | $0.00 derived: sum of 3 quarters · filed 2024-03-14 | $0.00 derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $0.00 derived: sum of 2 quarters · filed 2024-03-14 | $0.00 derived: sum of 3 quarters · filed 2024-03-14 | $7.55M 10-K · filed 2024-03-14 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $0.00 derived: sum of 2 quarters · filed 2022-11-07 | $7.55M 10-Q · filed 2022-11-07 | $34.31M derived: sum of 4 quarters · filed 2023-03-03 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $7.55M 10-Q · filed 2022-08-08 | $34.31M derived: sum of 3 quarters · filed 2023-03-03 | $51.61M derived: sum of 4 quarters · filed 2023-03-03 |
| 2022-03-31 | $7.55M 10-Q · filed 2022-05-06 | $34.31M derived: sum of 2 quarters · filed 2023-03-03 | $51.61M derived: sum of 3 quarters · filed 2023-03-03 | $78.14M derived: sum of 4 quarters · filed 2023-03-03 |
| 2021-12-31 | $26.75M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $44.05M derived: sum of 2 quarters · filed 2023-03-03 | $70.58M derived: sum of 3 quarters · filed 2023-03-03 | $70.58M 10-K · filed 2023-03-03 |
| 2021-09-30 | $17.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $43.83M derived: sum of 2 quarters · filed 2021-11-08 | $43.83M 10-Q · filed 2021-11-08 | $43.83M derived: sum of 4 quarters · filed 2022-03-01 |
| 2021-06-30 | $26.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $26.53M 10-Q · filed 2021-08-09 | $26.53M derived: sum of 3 quarters · filed 2022-03-01 | $21.42M derived: sum of 4 quarters · filed 2022-03-01 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-07 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | -$5.11M derived: sum of 3 quarters · filed 2022-03-01 | $7.72M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$5.11M derived: sum of 2 quarters · filed 2022-03-01 | $7.72M derived: sum of 3 quarters · filed 2022-03-01 | $103.68M 10-K · filed 2022-03-01 |
| 2020-09-30 | -$5.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $7.72M derived: sum of 2 quarters · filed 2020-11-06 | $103.68M 10-Q · filed 2020-11-06 | $103.68M derived: sum of 4 quarters · filed 2021-03-01 |
| 2020-06-30 | $12.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $108.79M 10-Q · filed 2020-08-06 | $108.79M derived: sum of 3 quarters · filed 2021-03-01 | $108.79M derived: sum of 4 quarters · filed 2021-03-01 |
| 2020-03-31 | $95.95M 10-Q · filed 2020-05-11 | $95.95M derived: sum of 2 quarters · filed 2021-03-01 | $95.95M derived: sum of 3 quarters · filed 2021-03-01 | $95.95M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | $0.00 10-K · filed 2021-03-01 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $0.00 derived: sum of 2 quarters · filed 2019-11-07 | $0.00 10-Q · filed 2019-11-07 | $15.08M derived: sum of 4 quarters · filed 2020-03-02 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $0.00 10-Q · filed 2019-08-05 | $15.08M derived: sum of 3 quarters · filed 2020-03-02 | $40.15M derived: sum of 4 quarters · filed 2020-03-02 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-09 | $15.08M derived: sum of 2 quarters · filed 2020-03-02 | $40.15M derived: sum of 3 quarters · filed 2020-03-02 | |
| 2018-12-31 | $15.08M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $40.15M derived: sum of 2 quarters · filed 2020-03-02 | $401.49M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $25.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $386.40M 10-Q · filed 2018-11-07 | ||
| 2018-06-30 | $361.34M 10-Q · filed 2018-08-09 | |||
| 2017-12-31 | $0.00 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |